Erk1/2 activation and modulation of STAT3 signaling in oral cancer
Ioannis Gkouveris(University of California, Los Angeles), Alexandra Sklavounou(National and Kapodistrian University of Athens), George Z. Rassidakis(Karolinska University Hospital), Nikolaos G. Nikitakis(United Hospital), Maria Karanikou(National and Kapodistrian University of Athens)
Cited by 69
Related Papers
High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma
|Molecular Cancer|2007|275
Mammalian Target of Rapamycin, a Molecular Target in Squamous Cell Carcinomas of the Head and Neck
|Cancer Research|2005|243
Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL
|Cancer Immunology Research|2019|181
Ameloblastoma in children
|Journal of Oral and Maxillofacial Surgery|2002|161
Clinicopathologic characterization of oral angioleiomyomas
|Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology|2002|139